DLA Piper's Pricing Rules

The Inflation Reduction Act Impacts on Pricing in the Life Sciences Industry

32 min · 23. loka 2024
jakson The Inflation Reduction Act Impacts on Pricing in the Life Sciences Industry kansikuva

Kuvaus

David Hamilton facilitates a conversation with Lisa LeCointe-Cephas, partner and co-chair of the Life Sciences sector at DLA Piper, Kirsten Axelsen, senior policy advisor at DLA Piper, and Celeste Saravia, vice president at Cornerstone Research, on the impacts of the Inflation Reduction Act on innovation, competition, and pricing in the life sciences industry. See omnystudio.com/listener [https://omnystudio.com/listener] for privacy information.

Kommentit

0

Ole ensimmäinen kommentoija

Rekisteröidy nyt ja liity DLA Piper's Pricing Rules-yhteisöön!

Aloita maksutta

14 vrk ilmainen kokeilu

Kokeilun jälkeen 7,99 € / kuukausi. · Peru milloin tahansa.

  • Podimon podcastit
  • 20 kuunteluaikaa / kuukausi
  • Lataa offline-käyttöön

Kaikki jaksot

7 jaksot

jakson Algorithmic Pricing 2.0: Analyzing the intersection of AI and antitrust law kansikuva

Algorithmic Pricing 2.0: Analyzing the intersection of AI and antitrust law

In this episode of the Pricing Rules podcast, David Hamilton is joined by Greg Casas, Antitrust partner at DLA Piper, Joe Kendall, AI director in DLA Piper’s PiperAI team, Salil Mehra, a professor of antitrust law at Temple University, and Ai Deng, Managing Director at BRG. The panel examines how algorithmic pricing cases are evolving beyond the pleading stage in antitrust litigation, including how courts are analyzing motions to dismiss, what constitutes an “agreement” under Section 1 of the Sherman Act, and the growing role of expert testimony—both economic and technical—in evaluating algorithm design, data inputs, and alleged coordinated conduct. See omnystudio.com/listener [https://omnystudio.com/listener] for privacy information.

10. huhti 202639 min